Aditxt, Inc. (ADTX)

↓ Download CSV

CIK 0001726711 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Aditxt, Inc. reported revenue of $3.2K, down 97.6% from the prior year. The company ran a net loss, with a net margin of -1349028.2% and a gross margin of 8.4%. It held $16.52M in total assets against $12.56M in total liabilities.

Key ratios (FY2025)

8.4%
Gross margin
-612542.2%
Operating margin
-1349028.2%
Net margin
-768.3%
Return on equity
-97.6%
Revenue growth (YoY)
Metric (FY)20252024202320222021202020192018
Revenue$3.2K$134.0K$645.2K$933.7K$105.0K
Cost of Revenue$2.9K$627.5K$756.8K$766.8K
Gross Profit$268-$493.5K-$111.7K$166.9K$27.1K
Operating Income-$19.57M-$27.86M-$26.06M-$25.48M-$41.93M-$8.87M-$5.87M
Net Income-$43.10M-$40.35M-$32.70M-$27.65M-$46.37M-$9.15M-$5.83M
EPS (Diluted)$-1153.83$-22147415.22$-27038.26$-595.60$-121.18
Total Assets$16.52M$32.14M$44.58M$10.74M$16.66M$13.10M$123.5K
Total Liabilities$12.56M$23.86M$28.53M$5.53M$6.48M$2.09M$2.98M
Shareholders' Equity$5.61M$1.67M$16.06M$5.21M$10.18M$11.01M-$2.85M-$1.54M
Cash & Equivalents$833.0K$97.1K$2.77M$7.87M$10.50M$4.1K$115.7K
Operating Cash Flow-$25.69M-$16.76M-$19.20M-$22.39M-$22.28M-$7.22M-$464.4K
Capital Expenditures$13.7K$14.4K$367.1K
Shares Outstanding411.5K193165107.6K888.6K12.97M3.82M